Search

everythinglearnresearchcommunity

for

Search:↓

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

Dutasteride may lower the chance of finding prostate cancer in men with enlarged prostates.

Tofacitinib might be used to treat hair loss.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Upadacitinib effectively treats severe alopecia areata and is safe.

Combination therapy for BPH is more effective in certain men but may not be cost-effective due to minimal impact and potential side effects.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Cancer treatments often cause skin, nail, and hair problems.

Nanoparticle delivery can reduce side effects of the cancer drug doxorubicin.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Using dutasteride during hair transplants improves results and reduces hair loss.

Individualized treatments may help manage Dercum's disease symptoms.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Adalimumab was safe but mostly ineffective for severe alopecia areata.

CDK4/6 inhibitors may cause hair loss in breast cancer patients.

Aumolertinib is effective and well-tolerated for treating advanced lung cancer with EGFR mutations.

Avemar may help in cancer treatment, but its effectiveness isn't proven yet.

Dutasteride showed some prevention of prostate issues but also had limitations, especially with high-grade tumors.

Kang'ai injection with FLO chemotherapy improves effectiveness and quality of life in advanced gastric cancer patients.

Doxorubicin causes heart damage, so early detection and monitoring are important during chemotherapy.

Lung cancer patients on immunotherapy and chemotherapy often experience severe fatigue, drowsiness, and appetite loss.